← All trials
NCT07217587
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 28, 2025
- Primary completion
- Sep 28, 2027
- Completion date
- Sep 4, 2028
- First posted
- Oct 16, 2025
- Last posted
- Oct 16, 2025
- Enrollment
- 115
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.